Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Home About Us My Account Personal Library Customer Service    
Welcome Guest
(login/register)
US: 800.298.5699
Int'l: +1.240.747.3093
Quick Search
Advanced Search >
Research Assistance
Send us a request >
Latest Research by Email
Receive email alerts of new market research reports in your industry.
Sign Up Today >
Home > Back to Category > Report Information Email a colleague | Printer format

Solvay Pharmaceuticals, Inc.

SGA Lists
October 1, 2009
4 Pages - Pub ID: SGA2459168
 
Questions about this report >
Order by fax >
XE.com
Abstract

Table of
Contents
Related Reports


Solvay Pharmaceuticals is dedicated to optimal patient health management. Our commitment is to contribute to an increasing portion of corporate growth, revenues and profit. Within our defined therapeutic areas, Solvay Pharmaceuticals intends to be among the leading global pharmaceuticals companies in providing health management. We will strengthen our position through global market presence and by marketing a product portfolio of unique and complete treatments. We will build our product portfolio through discovery, development, licensing and acquisition of pharmaceuticals. Our success will be based on attracting, developing and retaining talented and motivated employees with the ability and commitment to excel.

Related Reports:
Novartis (NVS) Profile & Health Care Industry Trends Analysis 2010
Eli Lilly & Company (LLY) Profile & Biotech Industry Trends Analysis 2010
GlaxoSmithKline (GSK) Profile & Health Care Industry Trends Analysis 2010
Roche Holding LTD (RHHBY) Profile & Health Care Industry Trends Analysis 2010
Merck & Co Inc. (MRK) Profile & Biotech Industry Trends Analysis 2010
Pfizer Inc (PFE) Profile & Biotech Industry Trends Analysis 2010
Sanofi-Aventis SA (SNY) Profile & Biotech Industry Trends Analysis 2010
Merck & Co. Performance, Products, Pipeline and Potential
Takeda Pipeline, Products, Performance, Potential
Company Financials: Bayer AG

Privacy Policy    |    Terms and Conditions    |    Site Map    |    Return Policy    |    Press    |    Help FAQs
Phone: 800.298.5699 (US) or +1.240.747.3093 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: customerservice@marketresearch.com
Copyright © 1999-2009, All Rights Reserved, MarketResearch.com
11/24/2009 - 3